Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 20 mg - tablet, film coated - excipient ingredients: titanium dioxide; microcrystalline cellulose; macrogol 4000; sodium lauryl sulfate; iron oxide red; lactose monohydrate; hypromellose; purified talc; croscarmellose sodium - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 20 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; microcrystalline cellulose; macrogol 4000; titanium dioxide; iron oxide red; lactose monohydrate; croscarmellose sodium; sodium lauryl sulfate - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 15 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; magnesium stearate; titanium dioxide; lactose monohydrate; iron oxide red; croscarmellose sodium; macrogol 4000; microcrystalline cellulose; hypromellose - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 15 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; magnesium stearate; iron oxide red; titanium dioxide; macrogol 4000; hypromellose - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 15 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; iron oxide red; titanium dioxide; magnesium stearate; sodium lauryl sulfate; macrogol 4000; microcrystalline cellulose; hypromellose - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; iron oxide red; sodium lauryl sulfate; macrogol 4000; croscarmellose sodium; titanium dioxide; hypromellose; microcrystalline cellulose - rivaroxaban is indicated for:,? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks).

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: titanium dioxide; croscarmellose sodium; iron oxide red; lactose monohydrate; macrogol 4000; magnesium stearate; sodium lauryl sulfate; hypromellose; microcrystalline cellulose - rivaroxaban is indicated for: ? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks).

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; lactose monohydrate; macrogol 4000; microcrystalline cellulose; titanium dioxide; iron oxide red; croscarmellose sodium; hypromellose; magnesium stearate - rivaroxaban is indicated for:,? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks).

Malta - English - Medicines Authority

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - rivaroxaban - film-coated tablet - rivaroxaban 10 mg - antithrombotic agents

Malta - English - Medicines Authority

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - rivaroxaban - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents